中國通才教育(02175.HK):接獲涉IPO及所得款項用途指控 續停牌
中國通才教育(02175.HK)公布,近日接獲有關公司首次公開發售認購及所得款項用途的指控。經考慮該等指控後,公司正安排委聘專家對指控進行獨立調查。董事會將刊發有關調查結果及其根據調查結果對指控的立場及意見的進一步公告。
顧及委聘專家對指控進行獨立調查及完成該調查所需的時間,其結果可能會影響公司及其附屬公司截至2022年8月31日止年度的綜合年度業績,審計工作尚無法完成,公司無法於2022年11月30日前刊發2022年年度業績。公司將於獨立調查完成及與公司核數師協定同意後刊發2022年年度業績。
公司續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.